Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Marshall Medical Center is expanding its use of the da Vinci Surgical System to include gynecological procedures. This ...
Inside UK’s first remote robotic surgery as surgeon operates on prostate cancer patient 2,400km away - A surgeon in London ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...
The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association (AUA), is pleased to announce the appointment ...
What began as a volunteer moment in a medical school ultrasound class turned into a life-changing discovery for Hannah Schultz — reshaping her future career path.
Interesting Engineering on MSN
Robot performs prostate surgery across 1,500 miles between London and Gibraltar
A surgeon in London has successfully removed a patient’s prostate in Gibraltar using a ...
Co., Ltd. (Healinno Tech), an innovator in AI-powered surgical robotics, has introduced the metaFlow Waterjet Surgical Robot, an ...
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by. Welcome to the Profound Medical Fourth Quarter 2025 Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results